Novel Therapeutic Targets for Managing Dyslipidemia.

Sathiyakumar, Vasanth; Kapoor, Karan; Jones, Steven R; Banach, Maciej; Martin, Seth S; Toth, Peter P

Sathiyakumar, Vasanth; Kapoor, Karan; Jones, Steven R; Banach, Maciej; Martin, Seth S; Toth, Peter P.

Afiliação

Sathiyakumar V; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kapoor K; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jones SR; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Banach M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.
Martin SS; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Welch Center for Prevention, Epidemiology, and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School
Toth PP; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Medicine, CGH Medical Center, Sterling, IL, USA. Electronic address: peter.toth@cghmc.com.

Trends Pharmacol Sci ; 39(8): 733-747, 2018 08.

Article em En | MEDLINE | ID: mdl-29970260

Assuntos

Aterosclerose/tratamento farmacológico; Dislipidemias/tratamento farmacológico; Acil Coenzima A/antagonistas & inibidores; Acil Coenzima A/genética; Proteínas Semelhantes a Angiopoietina/genética; Proteínas Semelhantes a Angiopoietina/metabolismo; Animais; Apolipoproteínas C/genética; Apolipoproteínas C/metabolismo; Aterosclerose/genética; Aterosclerose/metabolismo; Dislipidemias/genética; Dislipidemias/metabolismo; Humanos; Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia; Metabolismo dos Lipídeos/efeitos dos fármacos; Terapia de Alvo Molecular; Estudos Prospectivos

Palavras-chave

ATP citrate lyase; angiopoietin-like proteins 3 and 4; apoprotein C3; lipoprotein(a); lysosomal acid lipase; proprotein convertase subtilisin/kexin type 9

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Dislipidemias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Dislipidemias Idioma: En Ano de publicação: 2018 Tipo de documento: Article